KRAS and neoplasm: However, another study reports that rapamycin, an mTOR inhibitor, combined with (Hsp90) inhibitor IPI-504, causes tumor regression by promoting mitochondrial damage, oxidative stress, and autophagy in Kras/p53 mutant lung cancer and Nf1-deficient RAS-driven tumors (71).